These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20961167)

  • 1. Method to introduce mannitol powder to intubated patients to improve sputum clearance.
    Tang P; Chan HK; Rajbhandari D; Phipps P
    J Aerosol Med Pulm Drug Deliv; 2011 Feb; 24(1):1-9. PubMed ID: 20961167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel In-Line Delivery System to Administer Dry Powder Mannitol to Mechanically Ventilated Patients.
    Feng B; Tang P; Leung SS; Dhanani J; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):100-107. PubMed ID: 27754730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Proof-of-Principle Setup for Delivery of Relenza
    Leung SSY; Parumasivam T; Tang P; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2016 Feb; 29(1):30-35. PubMed ID: 25974393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming dose limitations using the orbital(®) multi-breath dry powder inhaler.
    Young PM; Crapper J; Philips G; Sharma K; Chan HK; Traini D
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):138-47. PubMed ID: 24004178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Apparatus to Deliver Mannitol Powder for Bronchial Provocation in Children Under Six Years Old.
    Tang P; Leung SS; Hor E; Ruzycki CA; Carrigy NB; Finlay WH; Brannan JD; Devadason S; Anderson SD; Sly PD; Samnick K; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):452-61. PubMed ID: 25844950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of device resistance and inhalation flow rate on the lung deposition of orally inhaled mannitol dry powder.
    Yang MY; Verschuer J; Shi Y; Song Y; Katsifis A; Eberl S; Wong K; Brannan JD; Cai W; Finlay WH; Chan HK
    Int J Pharm; 2016 Nov; 513(1-2):294-301. PubMed ID: 27639621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design.
    Farkas DR; Hindle M; Longest PW
    Ann Biomed Eng; 2015 Nov; 43(11):2804-15. PubMed ID: 25986955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.
    Glover W; Chan HK; Eberl S; Daviskas E; Verschuer J
    Int J Pharm; 2008 Feb; 349(1-2):314-22. PubMed ID: 17904774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.
    Zhu B; Young PM; Ong HX; Crapper J; Flodin C; Qiao EL; Phillips G; Traini D
    J Pharm Sci; 2015 Jul; 104(7):2169-76. PubMed ID: 25931324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particle aerosolisation and break-up in dry powder inhalers: evaluation and modelling of impaction effects for agglomerated systems.
    Wong W; Fletcher DF; Traini D; Chan HK; Crapper J; Young PM
    J Pharm Sci; 2011 Jul; 100(7):2744-54. PubMed ID: 21360707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
    Kaialy W; Nokhodchi A
    Eur J Pharm Sci; 2015 Feb; 68():56-67. PubMed ID: 25497318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of inhaled dry powder mannitol on mucus and its clearance.
    Daviskas E; Rubin BK
    Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-breath dry powder inhaler for delivery of cohesive powders in the treatment of bronchiectasis.
    Young PM; Salama RO; Zhu B; Phillips G; Crapper J; Chan HK; Traini D
    Drug Dev Ind Pharm; 2015 May; 41(5):859-65. PubMed ID: 24811055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis on risk factors of endotracheal cuff under inflation in mechanically ventilated patients].
    Fu Y; Xi X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Dec; 26(12):870-4. PubMed ID: 25476078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro evaluation of aerosol delivery through tracheostomy and endotracheal tubes using different interfaces.
    Ari A; Harwood RJ; Sheard MM; Fink JB
    Respir Care; 2012 Jul; 57(7):1066-70. PubMed ID: 22273459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the United States Pharmacopeia throat introduce de-agglomeration of carrier-free powder from inhalers?
    Tang P; Kwok PC; Tong Z; Yang R; Raper JA; Chan HK
    Pharm Res; 2012 Jul; 29(7):1797-807. PubMed ID: 22327971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of powder polydispersity on aerosol generation.
    Chew NY; Chan HK
    J Pharm Pharm Sci; 2002; 5(2):162-8. PubMed ID: 12207868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methacholine dry powder inhaler as a new tool for bronchial challenge test.
    Colombo G; Terzano C; Colombo P; Petroianni A; Ricci A; Buttini F
    Int J Pharm; 2008 Mar; 352(1-2):165-71. PubMed ID: 18055141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double lumen endotracheal tube for percutaneous tracheostomy.
    Vargas M; Servillo G; Tessitore G; Aloj F; Brunetti I; Arditi E; Salami D; Kacmarek RM; Pelosi P
    Respir Care; 2014 Nov; 59(11):1652-9. PubMed ID: 25161301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.